Morphine sulphate consumption by French drug users
Memo, OFDT, 16 p.
July 2014
The use of morphine sulphate outside of the scope of the therapeutic framework is not a new phenomenon. However, starting in 2000 and for a decade thereafter, such use appeared to be fairly controlled, geographically-contained and volatile over time. Since 2011 or so, there has been a rise in demand that is disparate, but geographically widespread.
Authors : Agnès Cadet-Taïrou, Michel Gandilhon
Download the PDF file (425 Ko)
Drugs in Europe
2019 EMCDDA European Drug Report
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
